Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pediatric Neurology
|
April 24, 2018
Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
Raed Alroughani, Rajiv Das, Natasha Penner, et al.
Neurology and Therapy
|
January 18, 2022
Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple Sclerosis
Mita Kuchimanchi, Howard Bockbrader, Nancy Dolphin, et al.
BMJ Neurology Open
|
March 8, 2021
Comparison of neurofilament light chain results between two independent facilities
Tobias Sejbaek, Jason P Mendoza, Natasha Penner, et al.
Advances in Therapy
|
September 21, 2019
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study
Michael J Palte, Angela Wehr, Mark Tawa, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 16, 2026
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model
Pratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Larisa Reyderman, Natasha Penner, Pratik Bhagunde, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
Pratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Steven Hersch, Michelle Gee, Thomas Doherty, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Natasha Penner, Sumit Rawal, Jagadeesh Aluri, et al.
NPJ Systems Biology and Applications
|
March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effects
Youfang Cao, Brian A Willis, Kanta Horie, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pediatric Neurology
|
April 24, 2018
Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
Raed Alroughani, Rajiv Das, Natasha Penner, et al.
Neurology and Therapy
|
January 18, 2022
Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple Sclerosis
Mita Kuchimanchi, Howard Bockbrader, Nancy Dolphin, et al.
BMJ Neurology Open
|
March 8, 2021
Comparison of neurofilament light chain results between two independent facilities
Tobias Sejbaek, Jason P Mendoza, Natasha Penner, et al.
Advances in Therapy
|
September 21, 2019
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study
Michael J Palte, Angela Wehr, Mark Tawa, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 16, 2026
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model
Pratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Larisa Reyderman, Natasha Penner, Pratik Bhagunde, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
Pratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Steven Hersch, Michelle Gee, Thomas Doherty, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Natasha Penner, Sumit Rawal, Jagadeesh Aluri, et al.
NPJ Systems Biology and Applications
|
March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effects
Youfang Cao, Brian A Willis, Kanta Horie, et al.
Page
of 2